Abstract 1453 BackgroundCombination of the hyperCVAD regimen and imatinib or dasatinib has produced long-term leukemia free responses in patients with Philadelphia chromosome positive acute lymphoblastic leukemia even without an allogeneic stem cell transplant.
http://ift.tt/1l58Qsl
http://ift.tt/1l58Qsl
No comments:
Post a Comment